AGP Executive Report
Last update: 8 minutes agoHealth Policy & Access: North Korea is expanding a “revolution in public health” with model hospitals, model pharmacies, and a wider medical insurance push, but unstable medicine supplies and volatile pricing are still limiting real benefits. Cancer Research & Drug Deals: Merck struck a up-to-$2.13B global licensing deal with China’s SciBrunch for SPR2015, an experimental oral KRAS G12D cancer therapy still in preclinical development. Nutrition & Public Health: A new global analysis in The Lancet Global Health finds chewing tobacco drives 251,000 deaths in 2023, with South Asia carrying the heaviest burden. Clinical Care Spotlight: Chinese surgeons reported a rare case of appendicitis where the appendix was completely concealed beneath the cecum’s outer layer, complicating diagnosis. Women’s Health & Awareness: A global survey tied to Menopause Awareness Month found many women don’t link menopause with eye health changes, despite high concern about vision. Sports Medicine & Chronic Conditions: Tennis player Emma Navarro said she’s skipping the rest of 2026 to manage RED-S and Hashimoto’s hypothyroidism after years of under-fueling. Food Safety: Local health inspections listed multiple restaurants with scores ranging from mid-90s to failures, underscoring ongoing food-borne illness prevention checks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Early Clinical Data Show KRAS Inhibitors Can Work in Cholangiocarcinoma]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29015387-946728116-ae63c7e65ca956fb4d26cc120cc8521b840b02a5-1920x1080-200x113.png)
